Leeds Conferences

Website http://www.annualcongress.com/uk/leeds-conferences | Edit Freely

Category Leeds Neuroscience Conferences, Leeds healthcare conferences Leeds Physics Conferences, Leeds Materials Science Conferences, Leeds Conferences, Leeds Molecular Biology Conferences, Leeds Agriculture Conferences

Deadline: February 04, 2017 | Date: March 04, 2017-March 05, 2017

Venue/Country: Leeds, UK, U.K.

Updated: 2016-12-28 16:53:59 (GMT+9)

Call For Papers - CFP

Market Analysis report: The global market value for pharmaceutical and biopharmaceutical contract manufacturing, research and packaging was $219.9 billion in 2012 and this market is estimated to reach $242.2 billion in 2013 and $374.8 billion by 2018, a five-year compound annual growth rate (CAGR) of 9.1. According to market analysis, employment trends in nursing sectors have been increased in the past 6 years. The statistic presents the total number of employed and self-employed nurses in the United Kingdom (UK) from 2010 to 2016. The Immunology market is expected to experience continued growth, from $61.5 billion in 2015 to $74.2 billion in 2022, at a compound annual growth rate of 2.71%. There is a very large pharmaceutical pipeline for immunology, consisting of 1,838 products in active development. The global neurovascular devices market is poised to reach $2,370.4 million by 2020, growing at a CAGR of 8.4% from 2015 to 2020. Overall, global spending on cancer drugs has risen at an annual rate of 6.5 percent for the past five years, but jumped 10.3 percent in 2014, a new report by the IMS Institute for Healthcare Informatics states. The total turnover in 2013 of the consulting engineering companies represented by 15 national associations is €26billion. There is great variety in market size with Spain, Sweden and Germany being the largest included in the survey. On an average, 40% of turn over for consulting engineers in Europe is due to private sector business. The global market for cardiac equipment growth had risen from $49.4 billion in 2013 to $52 billion and the market for heart-lung and pump machines grew from $2.6 billion in 2012 to $3.4 billion in 2014.